As a rule, the scientific events of the association will be held during the scientific conferences of ISFA. Besides, independent scientific congresses of the association are held. The results will be published. The official publication organ of the association is the publication organ of ISFA, the journal “Therapeutic Apheresis and Dialysis” (TAD). Results of the association’s scientific research will be published in said journal immediately after the completion of the project concerned.
E-ISFA, the European Group of ISFA, initiated a project in Germany to identify cardiometabolic high-risk patients in ambulatory practices. Those patients are in special need of attention because their cardiometabolic risks are regularly discovered too late. Early indications of the risks are often not taken seriously by the patients, and GPs usually focus on the actual complaint the patient is visiting the practice for. Nonetheless, the risk is real and in many cases the awareness for the risk increases only after an event has occurred.
Fortunately, sufficient information on the health state of the patient is usually available in the medical information system (MIS). With suitable tools this information can be used to assess the individual patients’ cardiovascular risk and bring identified high-risk patients to the doctor’s attention. The software tool used in the project allow investigating digital patient data very quickly, compliant to current data protection regulations, and all with little effort for the practice team.
We suggest to make use of the activities in the GP practices to not only identify the patients in need and bring them to the doctor’s attention but also to provide appropriate data for establishing a registry for patients with cardiometabolic risk. This registry, first on national and later international level, will then allow the community to get a clearer picture on the population’s cardiometabolic risk, the regionally different measures taken to reduce the individual risks and the actual effect of the chosen treatment options on the patient’s status of health and quality of life.